BIBAUD SCOTT A. 4
4 · Atomera Inc · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Atomera (ATOM) CEO Scott Bibaud Receives Performance-Based Awards
What Happened
Scott A. Bibaud, CEO, President and a director of Atomera Inc. (ATOM), was granted three performance-based derivative awards on March 11, 2026 totaling 341,840 underlying shares (170,920 + 85,460 + 85,460). Each grant is reported as an award/acquisition (code A) with an acquisition price of $0.00 (derivative securities). This is a grant of options/awards for compensation/retention rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-03-11; Form 4 filed: 2026-03-13 (filed within the two-business-day reporting window).
- Grants: 170,920; 85,460; and 85,460 shares (total 341,840) — each reported at $0.00 (derivative award).
- Shares owned after transaction: not specified in the filing.
- Footnotes (vesting and performance conditions):
- F1 (170,920): First 25% vests Mar 1, 2027; remaining 75% vests in 12 equal quarterly installments thereafter only if the 30‑day average VWAP reaches $20.00 within five years; otherwise none vest.
- F2 (85,460): Same schedule but $12.50 VWAP threshold.
- F3 (85,460): Same schedule but $7.50 VWAP threshold.
- Filing timeliness: Reported on 2026-03-13 for a 2026-03-11 transaction — filed within the required two-business-day period.
Context
These awards are performance- and time-based options (derivative securities). Vesting depends both on time (first 25% on Mar 1, 2027, then quarterly) and on achieving specified stock price thresholds over any 30 consecutive trading days within five years; if a threshold isn’t met for a given tranche within five years, that tranche does not vest and terminates. Because this is a grant (not a purchase or sale), it reflects compensation/retention actions rather than an insider buying or selling stock.
Insider Transaction Report
- Award
Performance Stock Option (right to buy)
[F1]2026-03-11+170,920→ 170,920 totalExercise: $5.10Exp: 2036-03-11→ Common Stock (170,920 underlying) - Award
Performance Stock Option (right to buy)
[F2]2026-03-11+85,460→ 85,460 totalExercise: $5.10Exp: 2036-03-11→ Common Stock (85,460 underlying) - Award
Performance Stock Option (right to buy)
[F3]2026-03-11+85,460→ 85,460 totalExercise: $5.10Exp: 2036-03-11→ Common Stock (85,460 underlying)
Footnotes (3)
- [F1]Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $20.00. In the event the $20.00 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.
- [F2]Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $12.50. In the event the $12.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.
- [F3]Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $7.50. In the event the $7.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.